Poster 43
- Kelley Tangredi
- May 23, 2023
- 1 min read
Updated: Jul 8, 2023
Long-Term Efficacy of Continuous Risankizumab in Psoriasis by Body Region: An Updated Integrated Analysis From the LIMMitless Open-Label Extension Study
Authors: Andrew Blauvelt, Melinda Gooderham, Mark Lebwohl, Cuiyong Yue, Michael Chen, Manish Patel, Huzefa Photowala, April Armstrong
Comments